This study shows that in a cervical cancer mouse model vaccination with a combination vaccine such as tetanus toxoid and TC-1/cGM-CSF (GVAX) regressed tumor growth and enhanced the overall survival of mice compared with mice receiving either tetanus toxoid or GVAX alone. This evidence concerns the gene CSF2 and cervical carcinoma.